Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Marcus Parton"'
Autor:
John B. Kisiel, Steven H. Itzkowitz, Ahmet Burak Ozbay, Leila Saoud, Marcus Parton, David Lieberman, Paul J. Limburg
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 1, Pp 55-62 (2022)
Background and Aims: Approximately 20%–30% of colorectal cancers (CRCs) arise from the serrated polyp pathway. CRC screening options have differential sensitivity to detect sessile serrated polyps (SSPs). We used the Colorectal Cancer and Adenoma I
Externí odkaz:
https://doaj.org/article/4a06efb196d94db0859fcc59c8ab88cc
Autor:
Deborah A. Fisher, Leila Saoud, Kristen Hassmiller Lich, A. Mark Fendrick, A. Burak Ozbay, Bijan J. Borah, Michael Matney, Marcus Parton, Paul J. Limburg
Publikováno v:
Cancer Medicine, Vol 10, Iss 8, Pp 2855-2864 (2021)
Abstract Background Real‐world data for patients with positive colorectal cancer (CRC) screening stool‐tests demonstrate that adenoma detection rates are lower when endoscopists are blinded to the stool‐test results. This suggests adenoma sensi
Externí odkaz:
https://doaj.org/article/047a18430d5f486e99ab14cbe42156ee
Autor:
Andrew Piscitello, Leila Saoud, A Mark Fendrick, Bijan J Borah, Kristen Hassmiller Lich, Michael Matney, A Burak Ozbay, Marcus Parton, Paul J Limburg
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244431 (2020)
BackgroundReal-world adherence to colorectal cancer (CRC) screening strategies is imperfect. The CRC-AIM microsimulation model was used to estimate the impact of imperfect adherence on the relative benefits and burdens of guideline-endorsed, stool-ba
Externí odkaz:
https://doaj.org/article/c1e40b1cc0c441d48ff4f834fefbc25b
Autor:
Steven H. Itzkowitz, John B. Kisiel, A. Burak Ozbay, David A. Lieberman, Marcus Parton, Paul J. Limburg, Leila Saoud
Publikováno v:
Gastro Hep Advances. 1:55-62
Background and Aims Approximately 20-30% of colorectal cancers (CRC) arise from the serrated polyp pathway. CRC screening options have differential sensitivity to detect sessile serrated polyps (SSPs). We used the CRC-AIM model to assess how the dete
Publikováno v:
Current medical research and opinion. 37(4)
Despite the availability of multiple screening modalities for early detection of colorectal cancer (CRC), participation rates remain well below guideline recommendation goals in the United States. This study analyzed and compared recent national tren
Autor:
Bijan J. Borah, Michael Matney, Marcus Parton, A. Burak Ozbay, A. Mark Fendrick, Deborah A. Fisher, Kristen Hassmiller Lich, Paul J. Limburg, Leila Saoud
BackgroundReal-world data for patients with positive colorectal cancer (CRC) screening stool-tests demonstrates that adenoma detection rates are lower when endoscopists are blinded to the stool-test results. This suggests adenoma sensitivity may be l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f729eb5521430cc2eac38fdaff70d945
https://doi.org/10.1101/2020.08.31.271924
https://doi.org/10.1101/2020.08.31.271924
Autor:
Steven H. Itzkowitz, Marcus Parton, John B. Kisiel, Paul J. Limburg, A. Burak Ozbay, Leila Saoud, David A. Lieberman
Publikováno v:
Journal of Clinical Oncology. 39:10545-10545
10545 Background: Approximately 20–30% of colorectal cancers (CRC) arise from the serrated polyp pathway. The multitarget stool DNA (mt-sDNA) test has greater sensitivity to detect sessile serrated polyps (SSPs) than a leading fecal immunochemical
Autor:
K. Hassmiller Lich, Ahmet B. Ozbay, Michael Matney, A.M. Fendrick, Leila Saoud, Paul J. Limburg, Andrew Piscitello, Marcus Parton, Bijan J. Borah
Publikováno v:
Value in Health. 23:S74-S75
Autor:
K. Hassmiller Lich, Michael Matney, Bijan J. Borah, Paul J. Limburg, Andrew Piscitello, Marcus Parton, Ahmet B. Ozbay, A.M. Fendrick, Leila Saoud
Publikováno v:
Value in Health. 23:S72-S73
Autor:
Michael Matney, Bijan J. Borah, Paul J. Limburg, Andrew Piscitello, A.M. Fendrick, Leila Saoud, Marcus Parton, K. Hassmiller Lich, Ahmet B. Ozbay
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244431 (2020)
PLoS ONE
PLoS ONE
Background Real-world adherence to colorectal cancer (CRC) screening strategies is imperfect. The CRC-AIM microsimulation model was used to estimate the impact of imperfect adherence on the relative benefits and burdens of guideline-endorsed, stool-b